BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2021
View Archived Issues
CSPC cleared to begin clinical trials in China with SYHX-1901 for rheumatoid arthritis and SLE
Read More
MatriSys licenses MSB-3163 for acne from UCSD
Read More
Preliminary phase I/II results for SGT-001 in DMD support its further investigation
Read More
First patient enrolled in phase IIa clinical study of ARQ-252 as potential treatment for vitiligo
Read More
Exelixis collaborates with Merck KGaA and Pfizer to evaluate XL-092 plus avelumab in UC
Read More
GSK and ViiV Healthcare patent compounds for HIV infection
Read More
Kainos Medicine synthesizes new CD73 inhibitors
Read More
Kukje Pharma presents new mPGES-1 inhibitors
Read More
Peptomyc obtains approval for first-in-human phase I/II study of Omomyc
Read More
AlzeCure Pharma AB describes new compounds for AD
Read More
Dual labeling study finds no evidence of pancreatic beta cell neogenesis
Read More
Allogene Therapeutics patents CART cells for cancer
Read More
Characterization of a new mouse model of Parkinson's disease
Read More
China's NMPA approves emergency use of recombinant protein subunit vaccine against COVID-19
Read More
Phase II interim analysis data presented for apitegromab in patients with SMA
Read More
Idera reports ORR endpoint data from phase III trial of tilsotolimod for advanced melanoma
Read More
Sarepta Therapeutics presents results for SRP-9001 gene therapy in nonhuman primates
Read More
Incyte reports phase III results with ruxolitinib for COVID-19-associated ARDS
Read More
FDA approves Arcalyst for recurrent pericarditis
Read More
PGT-121 is effective without effector functions
Read More
Phase II study of AMY-101 for periodontal inflammation and gingivitis meets endpoints
Read More
New phase Ib/II trial evaluates CM-24 in advanced cancer
Read More
